We are live on
!
Find out more
BSC
Brown Shipley & Co Portfolio holdings
AUM
$193M
1-Year Est. Return
26.64%
This Fund
S&P 500
This Quarter
Est. Return
+4.73%
1 Year Est. Return
+26.64%
3 Year Est. Return
+100.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$201M
AUM Growth
-$1.91M
(-0.94%)
Cap. Flow
-$7.15M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
65.97%
Holding
70
New
4
Increased
12
Reduced
32
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.92M |
| 2 |
Chevron
CVX
|
+$2.84M |
| 3 |
Synopsys
SNPS
|
+$1.06M |
| 4 |
Meta Platforms (Facebook)
META
|
+$581K |
| 5 |
Palo Alto Networks
PANW
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.14M |
| 2 |
Microsoft
MSFT
|
+$1.44M |
| 3 |
UnitedHealth
UNH
|
+$1.4M |
| 4 |
Tesla
TSLA
|
+$1.24M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$964K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.54% |
| 2 | Communication Services | 18.79% |
| 3 | Financials | 14.63% |
| 4 | Healthcare | 12.25% |
| 5 | Consumer Staples | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alibaba
BABA
$293B
| $55.3K | 0.03% |
652
+480
| +279% | +$45.3K |
|
52
Goldman Sachs
GS
$300B
| $50.4K | 0.03% |
88
-23
| -21% | -$12.8K |
|
53
Stryker
SYK
$125B
| $45K | 0.02% |
125
| – | – |
|
54
Booking.com
BKNG
$149B
| $44.7K | 0.02% |
225
| – | – |
|
55
Verizon
VZ
$195B
| $40.5K | 0.02% |
1,014
| – | – |
|
56
Johnson & Johnson
JNJ
$618B
| $40.5K | 0.02% |
280
-220
| -44% | -$34.1K |
|
57
Prologis
PLD
$135B
| $33.6K | 0.02% |
318
| – | – |
|
58
Costco
COST
$422B
| $32.1K | 0.02% |
35
| – | – |
|
59
Thomson Reuters
TRI
$42.8B
| $30.6K | 0.02% |
189
| – | – |
|
60
Netflix
NFLX
$299B
| $26.7K | 0.01% |
+300
| New | +$24.7K |
|
61
Mondelez International
MDLZ
$79.5B
| $19.5K | 0.01% |
327
| – | – |
|
62
Harvard Bioscience
HBIO
$27.5M
| $10.1K | 0.01% |
478
| – | – |
|
63
Warner Bros
WBD
$65.9B
| $9.97K | ﹤0.01% |
+943
| New | +$8.76K |
|
64
Moderna
MRNA
$21.8B
| $4.32K | ﹤0.01% |
+104
| New | +$4.97K |
|
65
Biogen
BIIB
$30B
| $3.36K | ﹤0.01% |
22
-26
| -54% | -$4.38K |
|
66
Bristol-Myers Squibb
BMY
$133B
| – | – |
-235
| Closed | -$12.2K |
|
67
Colgate-Palmolive
CL
$73.1B
| – | – |
-600
| Closed | -$62.3K |
|
68
Danaher
DHR
$137B
| – | – |
-465
| Closed | -$129K |
|
69
Philip Morris
PM
$297B
| – | – |
-520
| Closed | -$63.1K |
|
70
Roper Technologies
ROP
$38.8B
| – | – |
-182
| Closed | -$101K |
|
Similar funds
SCM
PA
DF
EAM
CA
WWC
JHA
AIM
Brown Shipley & Co's Q4 2024 Portfolio in Review
As of Q4 2024, Brown Shipley & Co held 70 positions worth $201M, down 0.94% from $203M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Brown Shipley & Co withdrew a net $7.15M in Q4 2024, closing 5 positions and reducing 32 holdings. Its most notable exit was Danaher, an estimated $129K position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Brown Shipley & Co opened a new position in Chevron worth $2.69M.
- Brown Shipley & Co's largest Q4 2024 buy was Chevron: 18,582 shares worth $2.69M.
- Brown Shipley & Co added most to Eli Lilly in Q4 2024, an estimated $2.92M increase.
- Brown Shipley & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $3.14M.
- Brown Shipley & Co fully exited Danaher in Q4 2024, selling an estimated $129K.
- Brown Shipley & Co's ten largest holdings make up 66% of its $201M portfolio in Q4 2024.
- Brown Shipley & Co opened 4 new positions and closed 5 in Q4 2024.
- Brown Shipley & Co's portfolio value fell 0.94% quarter-over-quarter to $201M.
Based on Brown Shipley & Co's 13F filing for Q4 2024, filed 18 Feb 2025.